Publications

State and local governments face rising cybersecurity risks that strain budgets, disrupt services, and erode public trust. Governments need targeted investments in modern infrastructure, continuous monitoring, and stronger third-party risk management to protect critical services.

R&D intensity of the United States federal government, measured as R&D investment relative to GDP, experienced a marked decline, from 0.62 percent to 0.28 percent.

Canada’s business R&D weakness is not mainly that too few firms do research. It is that too few Canadian firms reach the scale where R&D becomes globally significant, leaving Canada with lots of research activity but too few firms that commercialize and compete at industrial weight.

Canada’s cloud debate is asking the wrong question—control, not domestic ownership or server location, is what determines security and resilience in practice.

To the extent intervention is deemed necessary, ITIF respectfully urges the Competition and Markets Authority to avoid following the EU DMA’s path of heavy-handed regulation when it comes to potential steering measures in the app store space and instead look to other jurisdictions, like Japan, that have taken a more tailored and flexible approach.

After decades of bad advice that led many developing nations down the wrong path and ignored evidence against neoclassical dogma, the World Bank should have the courage to admit it was wrong.

Chinese firms with ties to Beijing—and in some cases China’s military—are quietly exploiting America’s open economy, taxpayer support, and weak post-acquisition oversight, and Congress should close those loopholes before more U.S. innovation and industrial capacity are used to advance China’s strategic aims.

Fifty-four members of Congress told Korea’s ambassador earlier this week: Stop targeting American tech companies—or risk the U.S.-Korea alliance itself.

Over the past 26 years, researchers on the International Space Station have produced roughly 4,000 research papers and have helped to develop treatments for several diseases, including cancer, Alzheimer’s, and heart disease.

The competitiveness of the auto industry of the United States has waxed and waned over the past 60 years and is clearly not the globally dominant behemoth it once was. To bolster the industry’s competitiveness, policymakers first must understand why it has faltered and the challenges it faces moving forward.